Cancer incidence in people with AIDS in Italy
Open Access
- 19 July 2010
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 127 (6), 1437-1445
- https://doi.org/10.1002/ijc.25153
Abstract
People with HIV/AIDS (PWHA) have increased risk of some cancers. The introduction of highly active antiretroviral therapies (HAART) has improved their life expectancy, exposing them to the combined consequences of aging and of a prolonged exposure to cancer risk factors. The aim of this study was to estimate incidence rates (IR) in PWHA in Italy, before and after the introduction of HAART, after adjusting for sex and age through direct standardization. An anonymous record linkage between Italian AIDS Registry (21,951 cases) and Cancer Registries (17.3 million, 30% of Italian population) was performed. In PWHA, crude IR, sex‐ and age‐standardized IR and age‐specific IR were estimated. The standardized IR for Kaposi sarcoma and non‐Hodgkin lymphoma greatly declined in the HAART period. Although the crude IR for all non‐AIDS‐defining cancers increased in the HAART period, standardized IR did not significantly differ in the 2 periods (352 and 379/100,000, respectively). Increases were seen only for cancer of the liver (IR ratio = 4.6, 95% CI: 1.3–17.0) and lung (IR ratio = 1.8, 95% CI: 1.0–3.2). Age‐specific IRs for liver and lung cancers, however, largely overlapped in the 2 periods pointing to the strong influence of the shift in the age distribution of PWHA on the observed upward trends. In conclusion, standardized IRs for non‐AIDS‐defining cancers have not risen in the HAART period, even if crude IRs of these cancers increased. This scenario calls, however, for the intensification of cancer‐prevention strategies, notably smoking cessation and screening programs, in middle‐aged HIV‐patients.Keywords
This publication has 30 references indexed in Scilit:
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyBritish Journal of Cancer, 2008
- Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003Annals of Internal Medicine, 2008
- Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individualsAIDS, 2008
- Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyAIDS, 2008
- Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysisThe Lancet, 2007
- Elevated Incidence of Lung Cancer Among HIV-Infected IndividualsJournal of Clinical Oncology, 2006
- Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral TherapyJNCI Journal of the National Cancer Institute, 2005
- Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in ItalyBritish Journal of Cancer, 1998
- Expanded European AIDS case definitionThe Lancet, 1993